Phenylketonuria: a review of current and future treatments.
Ontology highlight
ABSTRACT: Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme phenylalanine hydroxylase (PAH). If left untreated, the main clinical feature is intellectual disability. Treatment, which includes a low Phe diet supplemented with amino acid formulas, commences soon after diagnosis within the first weeks of life. Although dietary treatment has been successful in preventing intellectual disability in early treated PKU patients, there are major issues with dietary compliance due to palatability of the diet. Other potential issues associated with dietary therapy include nutritional deficiencies especially vitamin D and B12. Suboptimal outcomes in cognitive and executive functioning have been reported in patients who adhere poorly to dietar
SUBMITTER: Al Hafid N
PROVIDER: S-EPMC4728993 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA